Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−281.89 M USD
412.26 M USD
101.32 M
About Caris Life Sciences, Inc.
Sector
Industry
CEO
David Dean Halbert
Website
Headquarters
Irving
Founded
2008
FIGI
BBG00255V2N4
Caris Life Sciences, Inc. provides diagnostics and anatomic pathology services. It develops an unbiased profiling platform for novel target identification, drug development and delivery, diagnostic and disease monitoring, and precision medicine enabling aspects. It offers services throughout the U.S., Europe, Australia and other international markets. The company was founded by David D. Halbert in 2008 and is headquartered in Irving, TX.
Related stocks
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of CAI is 31.29 USD — it has increased by 8.61% in the past 24 hours. Watch Caris Life Sciences, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Caris Life Sciences, Inc. stocks are traded under the ticker CAI.
CAI stock has risen by 18.67% compared to the previous week, the month change is a 16.30% rise, over the last year Caris Life Sciences, Inc. has showed a 15.87% increase.
We've gathered analysts' opinions on Caris Life Sciences, Inc. future price: according to them, CAI price has a max estimate of 38.00 USD and a min estimate of 31.00 USD. Watch CAI chart and read a more detailed Caris Life Sciences, Inc. stock forecast: see what analysts think of Caris Life Sciences, Inc. and suggest that you do with its stocks.
CAI stock is 9.66% volatile and has beta coefficient of −0.40. Track Caris Life Sciences, Inc. stock price on the chart and check out the list of the most volatile stocks — is Caris Life Sciences, Inc. there?
Yes, you can track Caris Life Sciences, Inc. financials in yearly and quarterly reports right on TradingView.
Caris Life Sciences, Inc. is going to release the next earnings report on Sep 3, 2025. Keep track of upcoming events with our Earnings Calendar.
CAI net income for the last quarter is −102.58 M USD, while the quarter before that showed −111.03 M USD of net income which accounts for 7.61% change. Track more Caris Life Sciences, Inc. financial stats to get the full picture.
No, CAI doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, CAI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Caris Life Sciences, Inc. stock right from TradingView charts — choose your broker and connect to your account.